ATE87485T1 - Peptide der cholecystokinin-cerulein-gruppe enthaltende pharmazeutische zusammensetzungen zur behandlung von respiratorischen und herzkreislauf-insuffizienzen. - Google Patents

Peptide der cholecystokinin-cerulein-gruppe enthaltende pharmazeutische zusammensetzungen zur behandlung von respiratorischen und herzkreislauf-insuffizienzen.

Info

Publication number
ATE87485T1
ATE87485T1 AT87100015T AT87100015T ATE87485T1 AT E87485 T1 ATE87485 T1 AT E87485T1 AT 87100015 T AT87100015 T AT 87100015T AT 87100015 T AT87100015 T AT 87100015T AT E87485 T1 ATE87485 T1 AT E87485T1
Authority
AT
Austria
Prior art keywords
cholecystokinin
respiratory
treatment
pharmaceutical compositions
compositions containing
Prior art date
Application number
AT87100015T
Other languages
English (en)
Inventor
Alfio Bertolini
Original Assignee
Alfio Bertolini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfio Bertolini filed Critical Alfio Bertolini
Application granted granted Critical
Publication of ATE87485T1 publication Critical patent/ATE87485T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87100015T 1986-01-10 1987-01-02 Peptide der cholecystokinin-cerulein-gruppe enthaltende pharmazeutische zusammensetzungen zur behandlung von respiratorischen und herzkreislauf-insuffizienzen. ATE87485T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT19055/86A IT1204430B (it) 1986-01-10 1986-01-10 Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
EP87100015A EP0239716B1 (de) 1986-01-10 1987-01-02 Peptide der Cholecystokinin-Cerulein-Gruppe enthaltende pharmazeutische Zusammensetzungen zur Behandlung von respiratorischen und Herz-Kreislauf-Insuffizienzen

Publications (1)

Publication Number Publication Date
ATE87485T1 true ATE87485T1 (de) 1993-04-15

Family

ID=11154164

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87100015T ATE87485T1 (de) 1986-01-10 1987-01-02 Peptide der cholecystokinin-cerulein-gruppe enthaltende pharmazeutische zusammensetzungen zur behandlung von respiratorischen und herzkreislauf-insuffizienzen.

Country Status (8)

Country Link
US (1) US4794103A (de)
EP (1) EP0239716B1 (de)
JP (1) JP2534998B2 (de)
AT (1) ATE87485T1 (de)
DE (1) DE3785066T2 (de)
ES (1) ES2053454T3 (de)
IT (1) IT1204430B (de)
ZA (1) ZA87149B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1218472B (it) * 1985-08-30 1990-04-19 Alfio Bertolini Composizioni farmaceutiche comprendenti acht (1-24) per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
SE8901149D0 (sv) * 1989-04-03 1989-04-03 Pharmacia Ab Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
EP0522596A1 (de) * 1989-04-03 1993-01-13 Kabi Pharmacia AB Methode und Mittel zur Herbeiführung der Verengung der Augenpupille
JPH08500577A (ja) * 1992-07-15 1996-01-23 ユニヴァーシティ オブ サウス フロリダ パニック障害の治療に関連するｃｃｋペプチドの血中濃度
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
US20040001842A1 (en) * 1997-05-12 2004-01-01 Dov Michaeli Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
ATE361098T1 (de) * 1998-05-15 2007-05-15 Receptor Biologix Inc Vorbeugung und behandlung von hypergastrinemie
JP2003522105A (ja) * 1998-06-18 2003-07-22 チョワース、ミッチャル、ワイ． ヘリコバクター・ピロリ（Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ）関連疾患治療用医薬組成物
SE9901578D0 (sv) * 1999-05-03 1999-05-03 Karolinska Innovations Ab New use of substance in PNS
CA2441228A1 (en) 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
US20090191232A1 (en) 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
US6810583B2 (en) * 2001-08-07 2004-11-02 International Business Machines Corporation Coupling of conductive vias to complex power-signal substructures
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
JP4689597B2 (ja) * 2003-03-28 2011-05-25 レセプター バイオロジックス インク． ガストリンホルモン免疫アッセイ
CA2580965C (en) 2004-09-22 2014-04-08 Receptor Biologix, Inc. Monoclonal antibodies to progastrin
US20080077949A1 (en) * 2006-09-22 2008-03-27 Inventec Corporation Rotating data storage device anti-shake mechanism
JP7469225B2 (ja) 2017-06-15 2024-04-16 キャンサー アドヴァンシーズ インク． 腫瘍及び癌に対する体液性及び細胞性免疫を誘発するための組成物及び方法
RU2667466C1 (ru) * 2017-11-27 2018-09-19 Общество с ограниченной ответственностью "МЕДИНВЕСТ" Пептидное соединение, восстанавливающее функцию органов дыхания и обладающее иммуномодулирующим действием

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723406A (en) * 1969-12-23 1973-03-27 Squibb & Sons Inc Novel peptides having cholecystokinin activity and intermediates therefor
DE2256445C3 (de) * 1972-11-17 1981-11-05 Hoechst Ag, 6000 Frankfurt Heptapeptide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE3138233A1 (de) * 1981-09-25 1983-04-07 Farmitalia Carlo Erba S.p.A., 20159 Milano Neuropsychotropisches arzneimittel

Also Published As

Publication number Publication date
JP2534998B2 (ja) 1996-09-18
EP0239716B1 (de) 1993-03-31
EP0239716A3 (en) 1990-05-23
DE3785066T2 (de) 1993-07-08
DE3785066D1 (de) 1993-05-06
EP0239716A2 (de) 1987-10-07
IT1204430B (it) 1989-03-01
IT8619055A0 (it) 1986-01-10
JPS62246521A (ja) 1987-10-27
ES2053454T3 (es) 1994-08-01
ZA87149B (en) 1987-09-30
US4794103A (en) 1988-12-27

Similar Documents

Publication Publication Date Title
ATE87485T1 (de) Peptide der cholecystokinin-cerulein-gruppe enthaltende pharmazeutische zusammensetzungen zur behandlung von respiratorischen und herzkreislauf-insuffizienzen.
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
ATE185268T1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
DE69127470D1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
BG86132A (bg) Производни на пиридазинамин
DE122009000018I1 (de) Behandlung der pompeschen krankheit
ATE266043T1 (de) Peptidanaloge des menschlichen basischen myelinproteins
ES2150447T3 (es) Formas purificadas de desoxiribonucleasa.
DE69033521D1 (de) Verwendung von arginin als immunstimulator
DE69929188D1 (de) Lysin enthaltende peptide zur behandlung von herzkrankheiten
ATE411039T1 (de) Verwendung von thrombopoietin als medikament zur therapie und vorbeugung der thrombocytopenie
EP0264750A3 (de) Wachstumshormon-Releasingfaktor-Analoga
NO882239D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
NO882238D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
ATE79272T1 (de) Acth(1-24) enthaltende pharmazeutische zusammensetzungen zur therapie von schockzustaenden und von respiratorischen und herzkreislauf-insuffizienzen.
KR0126677B1 (ko) 항바이러스성 약제학적 조성물
JPS6426598A (en) Calcitonin gene related peptide derivative
OA08768A (fr) Traitement du virus su SIDA par l'interféron alpha humain recombinant.
Kohl Stimulation of human natural killer cytotoxicity and protection of mice from infection due to herpes simplex virus by recombinant human leukocyte interferon
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
IT8619086A0 (it) Composizioni farmaceutiche comprendenti frammenti di acth per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria.
DE4303530C2 (de) Pharmazeutische Verwendung eines Enkephalins
ES2036006T3 (es) Empleo de medicamentos con contenido de ifn-gamma para la prevencion y el tratamiento de enfermedades producidas por defectos inmunologicos primarios.